Member Info for Bridges

buy as much as they can as cheap as they can up to TR1 ;)

the cat is out of the bag and done out the cat flap

all the evidence leads to the conclusion that there is a large buyer in town

a knock on their door.

Russia will now come out with one 96% but maybe its only 50% with caveats that they could produce a billion shots but they haven't got the raw materials. In anycase what has that got to do with the price of SAR?

Going back to this thread we have SRA737 Final Data readouts from 2 completed clinical studies due out this week?
Thoth you raised a good point that if the data is good then it could be 30p to a quid once the analysts crunch the numbers.

What we need Damian is a mix of therapeutics and vaccines.

Otherwise is always a rub and in this case
leading expert warned that a limited supply of the raw ingredients needed for Covid vaccines such as Pfizer's risks leaving much of the world's population unprotected. The other rub is convincing people to take it. I won’t as I have already had covid twice abd last time I had a flu jab I reacted really badly and put my shoulder out of action for 12 months.

Thoth I agree something is building, some huge buys over the last few weeks; it’s either II or BO. Not sure which one but one of them. Some really huge swings in price action as well. There is a lot of news flow in a short space of time. SAR has a diverse pipeline with big potential, would you wait until price increases of would you start to buy as much as you can whilst you can?

Thanks Fadec for your response, just curious as you seem to know your subject matter; (along with many others on this board) Which area in your opinion is Sar key strength, in terms of the highest value commercial outcome.

Fadec just curious, obviously you don’t have to answer but are you invested in SAR?

We need to get above 3p (100m MC) and transfer onto the SETS system. SAR is worthy of this rather than the current state of getting played by the brokers the infamous MM’s. Looking forward to the re-rate.

Tumble weed

Andy none of which is priced into the sp

I think it is clear otherwise it would say
additional milestone payments of up to an aggregate of $319.5 million
to this
additional milestone payments of up to an aggregate of $29 Mill
and it doesnt

likewise its going from
additional milestone payments of up to an aggregate of $319.5 million
to this
additional milestone payments of up to an aggregate of $290.0
Mally needs to check their math

The opposite Damion, if you read between the lines. Sar now get cash quicker from milestone payments to enable focus and expenditure on our 100% owned products and where the real reward is.

I have set mine too but knowing the brokers they will lend them out anyway and only care about it once they have been found out. The main risk they have is if a big pharma or II starts aggressively buying them then someone will get caught short. Hence why they want to keep it below 3p

Great couple of days for off book forward selling, the smell still lingering but getting better.

its so obvious as well; will be above 2 p very soon. Big gap up to 2p